Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Stephen H, Bryant"'
Publikováno v:
Journal of Cheminformatics, Vol 10, Iss 1, Pp 1-9 (2018)
Abstract Background Fast and accurate identification of potential drug candidates against therapeutic targets (i.e., drug–target interactions, DTIs) is a fundamental step in the early drug discovery process. However, experimental determination of D
Externí odkaz:
https://doaj.org/article/200f396a903c4c4eb1c3a60335b0ec9b
Autor:
Thomas, Madej, Aron, Marchler-Bauer, Christopher, Lanczycki, Dachuan, Zhang, Stephen H, Bryant
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2112
The VAST+ algorithm is an efficient, simple, and elegant solution to the problem of comparing the atomic structures of biological assemblies. Given two protein assemblies, it takes as input all the pairwise structural alignments of the component prot
Autor:
Manoj Tyagi, Ratna R Thangudu, Dachuan Zhang, Stephen H Bryant, Thomas Madej, Anna R Panchenko
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e28896 (2012)
The coverage and reliability of protein-protein interactions determined by high-throughput experiments still needs to be improved, especially for higher organisms, therefore the question persists, how interactions can be verified and predicted by com
Externí odkaz:
https://doaj.org/article/3ab1ac73cac24d2bba3cd6617030b1b1
Publikováno v:
Slas Discovery
High-throughput screening (HTS) is now routinely conducted for drug discovery by both pharmaceutical companies and screening centers at academic institutions and universities. Rapid advance in assay development, robot automation, and computer technol
Publikováno v:
Bioinformatics. 33:1621-1629
Motivation Genetic variants in drug targets and metabolizing enzymes often have important functional implications, including altering the efficacy and toxicity of drugs. Identifying single nucleotide variants (SNVs) that contribute to differences in
Publikováno v:
Analytica Chimica Acta. 909:41-50
Identification of drug-target interactions (DTI) is a central task in drug discovery processes. In this work, a simple but effective regularized least squares integrating with nonlinear kernel fusion (RLS-KF) algorithm is proposed to perform DTI pred
Autor:
Stephen H. Bryant, Dachuan Zhang, Yanli Wang, Philippe Youkharibache, Renata C. Geer, Christopher J. Lanczycki, Gabriele H. Marchler, Lewis Y. Geer, Jiyao Wang, Lon Phan, Shennan Lu, Thomas Madej, Minghong Ward, Aron Marchler-Bauer
SummaryiCn3D (I-see-in-3D) is a web-based 3D molecular structure viewer focusing on the interactive structural analysis. It can simultaneously show 3D structure, 2D molecular contacts, and 1D protein and nucleotide sequences through an integrated seq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4e83e8d76416eff56cc2e4bf864aab7
https://doi.org/10.1101/501692
https://doi.org/10.1101/501692
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1825
PubChem ( https://pubchem.ncbi.nlm.nih.gov ) is a key chemical information resource, developed and maintained by the US National Institutes of Health. The present chapter describes how to find potential multitarget ligands from PubChem that would be
While novel technologies such as high-throughput screening have advanced together with significant investment by pharmaceutical companies during the past decades, the success rate for drug development has not yet been improved prompting researchers l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b20b2a7041a66c8e42633897084b981
https://europepmc.org/articles/PMC6781586/
https://europepmc.org/articles/PMC6781586/
Publikováno v:
Nucleic Acids Research
PubChem (http://pubchem.ncbi.nlm.nih.gov) is a public repository for information on chemical substances and their biological activities, developed and maintained by the US National Institutes of Health (NIH). PubChem contains more than 180 million de